Atrial Fibrillation Clinical Trials

A listing of Atrial Fibrillation medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35243

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Birmingham Alabama 35294

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Birmingham Alabama 35243

Patients are needed to participate in a clinical research study evaluating Reveal LINQ™ Insertable Cardiac Monitor for the treatment of Stroke, Acute

Arizona

UPDATED

Phoenix Arizona 85013

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Phoenix Arizona 85015

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Scottsdale Arizona 85251

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Tucson Arizona 85723

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Arkansas

UPDATED

Little Rock Arkansas 72204-1858

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Little Rock Arkansas 72211

A Phase 3 clinical study for patients with Atrial Fibrillation

California

UPDATED

Culver City California 90230

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Fremont California 94536

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Huntington Beach California 92648

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Long Beach California 90806

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

San Diego California 92121

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

View More ▼

UPDATED

San Diego California 92161

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Stockton California 95204

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Torrance California 90503

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Colorado

UPDATED

Lakewood Colorado 80228

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Connecticut

UPDATED

Norwalk Connecticut 06851

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Delaware

UPDATED

Wilmington Delaware 19803

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Florida

UPDATED

Altamonte Springs Florida 32714

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Aventura Florida 33180

Patients are needed to participate in a clinical research study evaluating Reveal LINQ™ Insertable Cardiac Monitor for the treatment of Stroke, Acute

UPDATED

Bradenton Florida 34209

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Clearwater Florida 33756

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Clearwater Florida 33756

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

View More ▼

UPDATED

Daytona Beach Florida 32114

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Fort Lauderdale Florida 33316

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Jacksonville Florida 32216

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Jacksonville Beach Florida 32250

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Jupiter Florida 33458

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Ocala Florida 34471

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Orlando Florida 32825

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Orlando Florida 32803

Patients are needed to participate in a clinical research study evaluating Reveal LINQ™ Insertable Cardiac Monitor for the treatment of Stroke, Acute

UPDATED

Palm Beach Gardens Florida 33410

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

St. Petersburg Florida 33701

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Tampa Florida 33613

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Wellington Florida 33449

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Georgia

UPDATED

Athens Georgia 30606

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Atlanta Georgia 30342

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Augusta Georgia 30912

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Covington Georgia 30014

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Idaho

UPDATED

Boise Idaho 83712

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Illinois

UPDATED

Chicago Illinois 60611-5928

Patients are needed to participate in a clinical research study evaluating Reveal LINQ™ Insertable Cardiac Monitor for the treatment of Stroke, Acute

UPDATED

Fairview Heights Illinois 62208

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Jerseyville Illinois 62052

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Normal Illinois 61761

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Indiana

UPDATED

Elkhart Indiana 46514

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Indianapolis Indiana 46202

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

UPDATED

Richmond Indiana 47374

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes

Iowa

UPDATED

Davenport Iowa 52803

A clinical trial to evaluate treatments using Apixaban, vitamin K antagonist, Acetylsalicylic acid and Acetylsalicylic acid placebo for patients with Acute Coronary Syndromes